agilon health, inc. (NYSE:AGL) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lessened its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 82.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 249,346 shares of the company's stock after selling 1,166,073 shares during the period. JPMorgan Chase & Co. owned 0.06% of agilon health worth $474,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter worth $25,000. Ieq Capital LLC acquired a new position in agilon health during the fourth quarter worth about $26,000. Signaturefd LLC increased its stake in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of agilon health in the 4th quarter worth about $33,000. Finally, Symphony Financial Services Inc. grew its position in shares of agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock valued at $44,000 after purchasing an additional 7,058 shares during the last quarter.

Analysts Set New Price Targets

A number of research firms recently issued reports on AGL. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. JMP Securities reaffirmed a "market perform" rating on shares of agilon health in a report on Monday, April 28th. Royal Bank of Canada lifted their price target on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Robert W. Baird dropped their price objective on agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Finally, Needham & Company LLC restated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $4.81.

agilon health Stock Down 1.3 %

NYSE:AGL traded down $0.06 on Monday, reaching $4.11. 3,618,842 shares of the stock traded hands, compared to its average volume of 5,864,959. The company's fifty day simple moving average is $4.23 and its 200 day simple moving average is $3.16. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a market capitalization of $1.70 billion, a price-to-earnings ratio of -4.37 and a beta of 0.38. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.